| scholarly article | Q13442814 |
| P50 | author | Kohei Togami | Q83501975 |
| P2093 | author name string | Hirokazu Suzuki | |
| Sumio Chono | |||
| Kazuhiro Morimoto | |||
| P2860 | cites work | Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D | Q22010373 |
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis | Q28207601 | ||
| The proteins of the surfactant system | Q28618896 | ||
| Surfactant Protein A Enhances Alveolar Macrophage Phagocytosis of Apoptotic Neutrophils | Q29392446 | ||
| A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity | Q34169361 | ||
| In vitro activity of OPC-17116 | Q34537966 | ||
| The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics | Q34804885 | ||
| The mutant selection window and antimicrobial resistance | Q35153856 | ||
| Pulmonary disposition of antimicrobial agents: methodological considerations | Q35447413 | ||
| Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients | Q35814807 | ||
| Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update | Q36072639 | ||
| Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes | Q37019180 | ||
| Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes | Q37861190 | ||
| Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages | Q38347205 | ||
| Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance | Q39828366 | ||
| Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins | Q40431109 | ||
| The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents | Q40517235 | ||
| The biology of bacterial colonization and invasion of the respiratory mucosa | Q40934639 | ||
| Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo | Q42042312 | ||
| Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials | Q42671287 | ||
| Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections | Q43048902 | ||
| Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture | Q43585474 | ||
| Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system | Q44278156 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aerosol | Q104541 |
| drug delivery | Q1392806 | ||
| P304 | page(s) | 367-372 | |
| P577 | publication date | 2010-09-06 | |
| P1433 | published in | Drug Development and Industrial Pharmacy | Q5308840 |
| P1476 | title | Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections | |
| P478 | volume | 37 |
| Q46401314 | 7-Ethyl-10-hydroxycamptothecin proliposomes with a novel preparation method: optimized formulation, characterization and in-vivo evaluation |
| Q47839368 | Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary absorption of encapsulated insulin compared with co-administered insulin |
| Q38340865 | Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand? |
| Q47959525 | Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β1 in A549, NCI-H441, and Calu-3 cells: Development of an in vitro model of respiratory epithelial cells in idiopathic pulmonary fibros |
| Q33858681 | Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers |
| Q37927017 | Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents |
| Q38552573 | Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy. |
| Q39662393 | Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluids on alveolar surfaces |
| Q58860164 | The Use of Nanoparticles for Antimicrobial Delivery |
Search more.